BioLife Solutions, Inc.

Software

BioLife Solutions Announces New evo® Cold Chain Customers

Leading Cell and Gene Therapy Companies are De-Risking Clinical Trial and Commercial Shipments by Using State of the Art Cloud-Connected Shippers and evo.is BOTHELL, Wash., Sept. 16, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers...

Read More »
Thermal & Heating Equipment

BioLife Solutions' CryoStor® Integrated in Kolon Group's Cell-Mediated Gene Therapy for Osteoarthritis

Approval to Market Invossa™ Filed with Korean Ministry of Food and Drug Safety BOTHELL, Wash. - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers ( BioLife" or the "Company"),...

Read More »
Health, Medical, & Dental Supplies and Equipment

BioLife Solutions Launches Two New Product Packaging Options for BloodStor® and CryoStor® Freeze Media

Single-Use Syringes and Bulk Dispensing Bags with Sterile Dockable Tubing Offer Improved Aseptic Processing of Clinical Cells and Tissues BOTHELL, Wash.Â- — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and...

Read More »
Company News

BioLife Solutions Ranked 403rd Fastest Growing Company in North America on Deloitte's 2020 Technology Fast 500™

BOTHELL, Wash., Nov. 19, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced it was ranked number 403 on Deloitte's Technology Fast 500™, a ranking of the 500 fastest-growing technology, media,...

Read More »
Software

BioLife Solutions Announces New evo® Cold Chain Customers

Leading Cell and Gene Therapy Companies are De-Risking Clinical Trial and Commercial Shipments by Using State of the Art Cloud-Connected Shippers and evo.is BOTHELL, Wash., Sept. 16, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced several new customers...

Read More »
Thermal & Heating Equipment

BioLife Solutions' CryoStor® Integrated in Kolon Group's Cell-Mediated Gene Therapy for Osteoarthritis

Approval to Market Invossa™ Filed with Korean Ministry of Food and Drug Safety BOTHELL, Wash. - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers ( BioLife" or the "Company"),...

Read More »
Health, Medical, & Dental Supplies and Equipment

BioLife Solutions Launches Two New Product Packaging Options for BloodStor® and CryoStor® Freeze Media

Single-Use Syringes and Bulk Dispensing Bags with Sterile Dockable Tubing Offer Improved Aseptic Processing of Clinical Cells and Tissues BOTHELL, Wash.Â- — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and...

Read More »

All Topics